News

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging ...
The global drug discovery market size to record USD 72.01 billion in 2025 and estimated to hit around USD 160.31 billion by 2034, growing at a CAGR of 9.3% during the forecast period from 2025 to 2034 ...
UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...
which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup has announced. Google ...
NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...
It came after he was jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their AI ...
Google DeepMind has released TxGemma, a new suite of open-source language models built to support therapeutic development.
Google unveils Ironwood, its seventh-generation TPU chip delivering 42.5 exaflops of AI compute power — 24x more than the world's fastest supercomputer — ushering in the "age of inference." ...
SandboxAQ, a startup drawing on quantum computing techniques to develop quantitative artificial intelligence models for ...
Google unveils Ironwood TPUs, Gemini 2.5 "thinking models," and Agent2Agent protocol at Cloud Next '25, challenging Microsoft and Amazon with a comprehensive AI strategy that enables multiple AI ...